Pesch Megan Honor, Brown Kevin David, Birath Amy L, Demmler-Harrison Gail J, Sapp Cailtin, Selleck Anne Morgan, Sweeney Alex D
Division of Developmental and Behavioral Pediatrics, Department of Pediatrics, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
National CMV Foundation, Tampa, Florida, USA.
Otolaryngol Head Neck Surg. 2025 Feb;172(2):728-733. doi: 10.1002/ohn.1079. Epub 2024 Dec 12.
It is estimated that 1 in every 200 US newborns has congenital cytomegalovirus (cCMV). Delayed identification of cCMV in newborns precludes timely intervention to mitigate sequelae of the infection such as hearing loss and other neurological complications. Newborn testing for cCMV enables appropriate diagnosis and intervention by multidisciplinary teams to properly manage the immediate sequelae of cCMV, avoid unnecessary additional testing that can result from delayed diagnosis, and monitor for future complications. It is the position of the American Cochlear Implant Alliance, the National CMV Foundation, and the American Academy of Otolaryngology-Head and Neck Surgery that universal newborn cCMV screening is necessary to best accomplish these goals.
据估计，美国每200名新生儿中就有1人患有先天性巨细胞病毒（cCMV）。新生儿cCMV的延迟识别会妨碍及时干预，以减轻感染的后遗症，如听力损失和其他神经并发症。对新生儿进行cCMV检测可使多学科团队进行适当的诊断和干预，以妥善处理cCMV的直接后遗症，避免因诊断延迟而导致的不必要的额外检测，并监测未来的并发症。美国人工耳蜗植入联盟、全国CMV基金会和美国耳鼻咽喉-头颈外科学会的立场是，普遍的新生儿cCMV筛查对于最好地实现这些目标是必要的。
